These data support the use of sequential teriparatide and denosumab to increase BMD in premenopausal women with severe osteoporosis.
No takes yet. Share an insight, caveat, or question.
Shane et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: